Motivation: Exome capture kits have capture efficiencies that range from 40 to 60%. A significant amount of off-target reads are from the mitochondrial genome. These unintentionally sequenced mitochondrial reads provide unique opportunities to study the mitochondria genome.
INTRODUCTION
Next-generation sequencing (NGS) has enabled high-throughput production of sequencing data at a low cost. Projects such as The Cancer Genome Atlas (TCGA) and the 1000 Genomes Project have generated huge amounts of sequencing data. NGS data are rich and informative and contain many off-target reads that are often ignored but which may be biologically relevant. Sequencing data outside capture regions can produce reliable variation data (Guo et al., 2012c) . Mitochondrial DNA (mtDNA) sequences are recoverable in exome sequencing data (Larman et al., 2012) , even when the mtDNA is not included in the target region. Picardi and Pesole (2012) also provided scripts for assembling mitochondrial genome exome sequencing data. Based on those findings, we designed and implemented a tool, MitoSeek, for high-throughput secondary mitochondrial data mining from exome sequencing data or whole genome sequencing data. MitoSeek extracts mitochondrial information from exome sequencing data and performs analyses on four major mitochondrial factors: heteroplasmy, somatic mutations, relative copy number variation and large structural changes.
METHODS

Mitochondrial sequence extraction
Compared with the scripts released by Picardi and Pesole (2012) , which extract mtDNA reads and reassemble the mitochondrial genome from exome sequencing data, MitoSeek can extract mitochondrial genome information directly from a BAM file and also perform mitochondrial genome assembly. To deal with mtDNA homologous regions in the nuclear genome, MitoSeek uses a conservative approach, which uses reads unmapped to nuclear genome for the mtDNA assembly. However, choosing to reassemble the mitochondrial genome requires a significantly longer running time.
Quality control
Before conducting any analysis, MitoSeek will first produce a mitochondrial alignment quality control report, which contains important statistics such as average depth, percent of base pairs covered, base quality distribution, mapping quality distribution and insert size distribution. These quality control parameters serve as important confidence indicators for the downstream mitochondrial analysis. MitoSeek filters reads based on mapping quality score (MQ 20Þ and base quality score (BQ 20Þ. The threshold of the filters is adjustable by the user.
Heteroplasmy detection
The most crucial factor for detecting heteroplasmy is depth. The ideal sequencing technique for detecting heteroplasmy in mitochondria is mitochondria-targeted sequencing, which is capable of generating depths of up to 10 000 and detecting heteroplasmy as low as 0.1%. The depth for mtDNA in exome sequencing data is significantly lower, which limits the detectable heteroplasmy to 1%. Based on the alignment quality control report, MitoSeek will automatically adjust the heteroplasmy detection threshold to the most appropriate level. The heteroplasmy detection threshold is defined on one of two scales: read count or read percentage at a given location. For example, a user can specify the number of raw reads that are required to show support for heteroplasmy, or the percentage of reads that are required to show support for heteroplasmy. The heteroplasmy empirical filters follow Guo et al. (2012a) .
In addition to the empirical filters, we implemented a statistical framework to assess heteroplasmy. MitoSeek performs a one-tail Fisher's exact test to determine if the rate of heteroplasmy at each site is greater than zero or a user-defined threshold. Phred quality scores of heteroplasmy are also reported by MitoSeek.
Somatic mutation detection
Current genotype callers such as GATK's Unified Genotyper (McKenna et al., 2010) and glfMultiple are designed for a diploid genome. Using those genotype callers on a haploid genome where only a single allele is *To whom correspondence should be addressed. expected will generate inaccurate results. To solve this problem, MitoSeek compares the empirical allele counts between tumor and normal samples directly instead of using a genotype caller. MitoSeek can extract empirical allele counts for every mitochondrial position and then compare the allele counts between tumor and normal to determine somatic mutation status.
Relative copy number estimation
MtDNA copy number can be obtained through NGS data (Castle et al., 2010) . MitoSeek estimates the relative mtDNA copy number through exome and whole genome sequencing data. These are not absolute measurements of mtDNA copy number. The method takes advantage of the proportion of mitochondrial reads captured during exome and whole genome sequencing. The relative mtDNA copy number is computed as CN ¼ Rm 2RT , where R m is the reads aligned to mitochondria that passed the quality filter and R T is the total reads that passed the quality filter. Alternatively, relative mtDNA copy number can be computed as
, where D m is the average depth of mtDNA, and D E is the average depth of the exome. If whole genome data are used, D E will be replaced with D T , where D T is the average depth across the whole genome excluding mitochondria.
Structural mtDNA change
MitoSeek also reports mtDNA structural changes when pair-end sequencing data are used. The structural changes include mitochondria-nuclear genome integration and large deletion in mitochondria. Nuclear genome integration is a known phenomenon, which has been documented by multiple studies (Mourier et al., 2001; Timmis et al., 2004) , and it can be detected through discordant read pairs. Large deletion in mtDNA is a well-studied mtDNA dysfunction (Chen et al., 2011) , and MitoSeek detects it through identifying abnormal insert sizes.
Other features
The most common sequencing alignment reference for the human is HG19; however, the most accepted mitochondria reference is the revised Cambridge Reference sequence (rCRS) (Andrews et al., 1999) (GenBank: NC_012920) . MitoSeek can interchange genomic positions and reference nucleotides between HG19 and rCRS. Annotation of amino acid changes and identification of known pathogenic mutations are reported by MitoSeek in both HG19 and rCRS coordinates.
RESULT
We downloaded exome sequencing data on 10 normal-paired breast cancer tumor samples from TCGA and tested MitoSeek using those data. An example of heteroplasmy identified by MitoSeek can be viewed in Figure 1 . An example of a full report from a MitoSeek run can be seen in the Supplementary Material. MitoSeek is written in Perl and Linux Shell Script. The typical run time on exome sequencing data with BAM file size of 11 GB is 50 min on a 2.4 GHz CPU with 1 GB of memory.
DISCUSSION
Owing to the limitation of exome sequencing data, MitoSeek is not capable of calculating absolute copy number of mtDNA, only relative mtDNA copy number. Also, owing to noise in the sequencing data, MitoSeek is more suited to detecting large copy number variation rather than small copy number variation. MitoSeek is designed to work with paired-end sequencing data rather than single-end sequencing data given the large abundance of paired-end sequencing data. MitoSeek is designed with accessibility in mind. It considers many unique parameters that have not been implemented by other genome analysis tools. It is the only sequencing analysis tool that reports allele counts separately by forward and reverse strands, critical information for assessing strand bias (Guo et al., 2012b) . MitoSeek creates opportunities for high-throughput mitochondrial sequencing data mining from existing large exome sequencing databases.
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